CXCR2 Signaling and Remyelination in Preclinical Models of Demyelination

17Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The chemokine receptor CXCR2 is a receptor for CXC chemokines, including CXCL1 and CXCL2. CXCR2 is expressed by resident cells of the central nervous system, including neurons, microglia, oligodendrocyte progenitor cells (OPCs), and oligodendrocytes. CXCR2 signaling is important in regulating OPC biology with regard to positional migration and myelination during development. More recently, studies have argued that CXCR2 is involved in controlling events related to remyelination after experimentally induced demyelination. This review examines the concept that targeting CXCR2 may offer a novel therapeutic target for promoting remyelination.

Cite

CITATION STYLE

APA

Skinner, D. D., & Lane, T. E. (2020). CXCR2 Signaling and Remyelination in Preclinical Models of Demyelination. DNA and Cell Biology, 39(1), 3–7. https://doi.org/10.1089/dna.2019.5182

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free